Tuberous sclerosis is a genetic condition that causes benign tumors across multiple organ systems.

Health · Published 30 September 2026 Swipe more like this →

In short: Tuberous sclerosis complex is a rare genetic disorder that triggers the growth of benign tumors in the brain, heart, kidneys, and skin. While symptoms vary widely, the condition is driven by mutations in genes that normally suppress tumor growth, leading to complex neurological and physical manifestations throughout a patient's life.

Tuberous sclerosis complex (TSC) is an autosomal dominant disorder, meaning it can be inherited from an affected parent or arise from a spontaneous de novo mutation. These mutations occur in either the TSC1 or TSC2 genes, which produce the proteins hamartin and tuberin. These proteins function as tumor suppressors by regulating cell proliferation and differentiation; when they fail, the body loses its ability to control cell growth, leading to the formation of benign tumors known as hamartomas.

The clinical presentation of TSC is remarkably diverse, affecting nearly every organ system. In the brain, patients may develop cortical tubers or subependymal nodules, which can lead to seizures, intellectual disability, and developmental delays. Nearly 90% of individuals experience neurodevelopmental or psychiatric challenges, including autism spectrum disorder and ADHD. Dermatological signs are also highly prevalent, appearing in 96% of cases, ranging from hypomelanic macules at birth to facial angiofibromas that emerge during childhood.

Internal organs are frequently involved as well. Cardiac rhabdomyomas are common in children under two years old, while renal angiomyolipomas affect up to 80% of patients. These kidney tumors carry a risk of catastrophic hemorrhage if they exceed 4 cm in size. Because TSC involves mutations in tumor suppressor genes that follow the two-hit hypothesis, the disease exhibits wide expressivity, meaning that even within the same family, the severity of symptoms can differ significantly between individuals.

Despite the complexity of the disorder, most patients maintain a normal life expectancy with routine medical care. Researchers continue to study the molecular mechanisms behind TSC, including how the loss of hamartin and tuberin affects mTOR signaling and autophagy. Understanding these pathways is critical, as it provides insight into how these benign growths develop and how they might be managed clinically.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• Neurofibromatosis tumours grow from the nerves' support cells, not neurons
• Spinocerebellar ataxia is not one disease, but a diverse family of progressive genetic disorders.
• Medulloblastoma is a fast-growing brain tumor that requires precise genetic classification for effective treatment.
• Prion diseases are fatal, mysterious brain disorders caused by misfolded proteins, not viruses or bacteria.
• Sarcoidosis is a mysterious inflammatory condition that can affect almost any human organ
• The turkey vulture possesses a superpower that allows it to thrive on rotting flesh.
• Butter, olive oil and your body fat share one simple molecular shape
• From Dirt Tracks to Data Streams: The Unlikely Intersection of Racing and Genomics
• Why a dentist can numb exactly half your jaw and nothing else
• Typhoid is not typhus—the names fooled doctors for centuries
• An antidepressant became a go-to sleep drug despite a guideline against it
• Three typhus diseases, three different biting carriers

More in Health, medicine and disease · More in Health · Latest · A–Z · All topics